Workboat Indexes

Markets:

Overview

News

Currencies

International

Treasuries

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY:HLN)

11.19 -0.08 (-0.75%)

Streaming Delayed Price Updated: 11:41 AM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 Next >

Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M ↗

June 26, 2024

Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories SA for £500 million ($632 million). This strategic move allows Haleon to focus on growth...

Via Benzinga

Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business

June 26, 2024

From Dr. Reddy’s Laboratories Ltd.

Via Business Wire

Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC ↗

June 26, 2024

Sanofi wants $20 billion for its consumer health division, attracting interest from major firms like Advent and PAI Partners.

Via Benzinga

Current Analysis: Haleon ↗

March 12, 2024

Haleon (HLN) is one of the largest consumer health companies in the world. Over the past year, Haleon PLC share price rose 13.8% from $7.60 to $8.66 as of Tuesday’s market close.

Via Talk Markets

Earnings Scheduled For February 29, 2024 ↗

February 29, 2024

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.

Via Benzinga

Haleon Earnings Preview ↗

February 28, 2024

Via Benzinga

GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale ↗

May 17, 2024

GSK is fully exiting its position and will no longer hold any ordinary shares in Haleon, maker of Sensodyne toothpaste and Advil painkillers.

Via Benzinga

Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B ↗

March 18, 2024

Pfizer to reduce stake in Haleon to approximately 24% following earlier divestment announcement. Offer price per share to be revealed post book-building process by Haleon.

Via Benzinga

Advil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock Soars ↗

February 29, 2024

Haleon reports FY 2023 revenue growth of 4.1% to £11.3 billion ($14.03 billion), missing consensus. Adjusted operating profit rises 10.4% to £2.55 billion. CEO Brian McNamara outlines solid financial...

Via Benzinga

Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls ↗

January 26, 2024

A Robitussin recall is underway for two of the company's products after discovering microbial contamination of its cough syrups.

Via InvestorPlace

Robitussin Recall: Here Are The Products Impacted And What You Need To Know ↗

January 25, 2024

Haleon PLC (NYSE: HLN) announced a product recall of some of its Robitussin brand cough syrups. What Happened: A microbial contamination in Robitussin cough syrups could potentially cause...

Via Benzinga

Peering Into Haleon's Recent Short Interest ↗

January 16, 2024

Via Benzinga

How Is The Market Feeling About Haleon? ↗

December 28, 2023

Via Benzinga

Looking Into Haleon's Recent Short Interest ↗

December 01, 2023

Via Benzinga

How Is The Market Feeling About Haleon? ↗

November 15, 2023

Via Benzinga

GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M ↗

January 17, 2024

GSK sells 300M shares in Haleon at £326/share, raising £978M. GSK to retain 4.2% stake.

Via Benzinga

3 cheap 'stock'-ing stuffers Wall Street is bullish on

December 07, 2023

These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders.

Via MarketBeat

Topics Stocks

Health exclusion affects more than three in five people globally

November 20, 2023

From Haleon

Via GlobeNewswire

Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B ↗

November 16, 2023

Sanofi SA (NYSE: SNY) has reportedly initiated talks with Rothschild & Co. to explore the possibility of spinning off its consumer health division, which could potentially value the business at over...

Via Benzinga

A Look Into Haleon Inc's Price Over Earnings ↗

October 30, 2023

Via Benzinga

How Is The Market Feeling About Haleon? ↗

October 24, 2023

Via Benzinga

Peering Into Haleon's Recent Short Interest ↗

September 15, 2023

Via Benzinga

How Is The Market Feeling About Haleon? ↗

August 30, 2023

Via Benzinga

7 Healthcare Stocks to invest in for a Healthy Future ↗

October 20, 2023

Considering today's economic uncertainty and market turns, healthcare stocks may be one of the few winning sectors. Here are the winners.

Via InvestorPlace

GSK: Pharma Giant Prioritizing Shareholder Dividends ↗

October 13, 2023

A good hunting ground for dividend stocks is often companies from which Wall Street wants to see strong performance in the short-term, while its long-term prospects are actually what are most bright.

Via Talk Markets

Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories ↗

October 06, 2023

Bloomberg Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger

Via Benzinga

GSK Cuts Stake In Consumer Healthcare Business Haleon, Raises Around $1B ↗

October 06, 2023

GSK Plc (NYSE: GSK) said it raised £885.6 million (

Via Benzinga

How Is The Market Feeling About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)? ↗

October 05, 2023

Via Benzinga

New global study discovers people in pain feel more socially excluded than ever

September 28, 2023

From Haleon

Via GlobeNewswire

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗

September 12, 2023

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Workboat Indexes

Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (NY:HLN)

All News about Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

Corvus Energy battery systems selected for new Washington State Ferries hybrids

All American Marine to build second tour boat for Phillips Cruises

Tidewater to acquire Wilson Sons Ultratug for $500 million

Dredging underway at the Port of Brunswick